Emara Khalid E, Al Abdulsalam Omar, Al Habash Ahmed
From the Pediatric Ophthalmology Division (Emara), Dhahran Eye Specialist Hospital, Dhahran, Saudi Arabia; Department of Ophthalmology (Al Abdulsalam), King Abdulaziz Hospital, Al Ahsa, National Guard Health Affairs, Saudi Arabia; Department of Ophthalmology (Al Habash), University of Dammam, Dammam, Saudi Arabia.
From the Pediatric Ophthalmology Division (Emara), Dhahran Eye Specialist Hospital, Dhahran, Saudi Arabia; Department of Ophthalmology (Al Abdulsalam), King Abdulaziz Hospital, Al Ahsa, National Guard Health Affairs, Saudi Arabia; Department of Ophthalmology (Al Habash), University of Dammam, Dammam, Saudi Arabia.
J Cataract Refract Surg. 2015 Nov;41(11):2458-65. doi: 10.1016/j.jcrs.2015.05.035.
To evaluate the safety and efficacy of implantation of the Visian Implantable Collamer Lens phakic intraocular lens (pIOL) (spherical and toric models) for management of amblyopia due to anisometropic hyperopia and myopia in children.
Retrospective case series.
Tertiary care eye specialty hospital, Dhahran, Saudi Arabia.
Eyes of patients who underwent the implantation of the pIOL for refractory anisometropic amblyopia were identified. None of the patients were compliant with spectacle/contact lens correction. Preoperative and postoperative clinical evaluation included visual acuity, cycloplegic refraction, slitlamp microscopy, intraocular pressure, orthoptic evaluation, anterior chamber depth, and ICL vault.
A total of 11 eyes (9 myopic, 2 hyperopic) of 11 patients aged 5 to 15 years were identified. Of the 9 myopic eyes, 6 eyes received spherical ICLs and 3 received toric ICLs. Both hyperopic eyes received spherical ICLs. Preoperatively, the mean cycloplegic refractive spherical equivalent (CRSE) was -11.07 D (range -7.75 to -21.88 D) in myopic eyes, and +8.75 D (range +8.63 to +8.87 D) in hyperopic eyes. The mean corrected distance visual acuity (CDVA) was 20/171 (range 20/40 to 20/400) in myopic eyes, and 20/130 (range 20/60 to 20/200) in hyperopic eyes. At a mean follow-up of 16.8 months (in myopic eyes), the mean CRSE was -1.40 D (range 0 to -2.25 D), and mean CDVA was 20/51 (range 20/20 to 20/100). In hyperopic eyes, at a mean follow-up of 15 months, the mean CRSE was +1.82 D (range +1.75 to +1.88 D) and the CDVA had improved to 20/25 in both eyes. Although complications occurred in the 2 hyperopic eyes, the complications were either temporary or visually insignificant and did not necessitate reoperation or ICL explantation.
ICL implantation may be considered a safe and effective treatment option for refractory amblyopia due to anisometropic hyperopia or myopia in children who are noncompliant with conventional therapy.
The authors have no financial or proprietary interest in a product, method, or material described herein.
评估植入Visian可植入式角膜胶原晶状体有晶状体眼人工晶状体（pIOL）（球面和环曲面模型）治疗儿童屈光参差性远视和近视所致弱视的安全性和有效性。
回顾性病例系列。
沙特阿拉伯达兰的三级眼科专科医院。
确定接受pIOL植入治疗难治性屈光参差性弱视的患者的眼睛。所有患者均不依从眼镜/隐形眼镜矫正。术前和术后临床评估包括视力、睫状肌麻痹验光、裂隙灯显微镜检查、眼压、斜视评估、前房深度和ICL拱高。
共确定了11例年龄在5至15岁患者的11只眼（9只近视眼，2只远视眼）。9只近视眼中，6只眼植入了球面ICL，3只眼植入了环曲面ICL。2只远视眼均植入了球面ICL。术前，近视眼的平均睫状肌麻痹屈光球镜当量（CRSE）为-11.07 D（范围为-7.75至-21.88 D），远视眼为+8.75 D（范围为+8.63至+8.87 D）。近视眼的平均矫正远视力（CDVA）为20/171（范围为20/40至20/400），远视眼为20/130（范围为20/60至20/200）。近视眼平均随访16.8个月时，平均CRSE为-1.40 D（范围为0至-2.25 D），平均CDVA为20/51（范围为20/20至20/100）。远视眼平均随访15个月时，平均CRSE为+1.82 D（范围为+1.75至+1.88 D），双眼CDVA均提高到20/25。虽然2只远视眼出现了并发症，但这些并发症要么是暂时性的，要么对视力影响不大，无需再次手术或取出ICL。
对于不依从传统治疗的儿童屈光参差性远视或近视所致难治性弱视，ICL植入可被视为一种安全有效的治疗选择。
作者对本文所述的产品、方法或材料没有财务或所有权权益。
Zotero 插件